Dolby Laboratories, Inc.
New York Stock ExchangeTotal Valuation
Dolby Laboratories, Inc. carries a market capitalization of 5.94B, placing it among publicly traded companies globally. Its enterprise value stands at 4.31B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.94B |
| Enterprise Value | 4.31B |
Share Statistics
Dolby Laboratories, Inc. currently has 93.65M shares outstanding.
| Shares Outstanding | 93.65M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Dolby Laboratories, Inc. trades at a trailing price-to-earnings ratio of 174.90. The price-to-sales ratio is 3.69, and the price-to-book ratio stands at 1.91.
| PE Ratio | 174.90 |
| PS Ratio | 3.69 |
| PB Ratio | 1.91 |
| P/TBV Ratio | 2.94 |
| P/FCF Ratio | 9.60 |
| P/OCF Ratio | 11.43 |
Enterprise Valuation
On an enterprise value basis, Dolby Laboratories, Inc. trades at an EV/EBITDA multiple of 11.80 and an EV/FCF ratio of 8.21. The EV/Sales ratio of 3.18 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 16.46 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.18 |
| EV / EBITDA | 11.80 |
| EV / EBIT | 16.46 |
| EV / FCF | 8.21 |
Financial Position
Dolby Laboratories, Inc. maintains a current ratio of 3.19, meaning it holds 3.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.19 |
| Quick Ratio | 2.79 |
| Debt / Equity | 1.83 |
| Debt / EBITDA | 0.13 |
| Interest Coverage | N/A |
Financial Efficiency
Dolby Laboratories, Inc. posts a return on equity of 1.10 and a return on invested capital of 8.16.
| Return on Equity (ROE) | 1.10 |
| Return on Assets (ROA) | 0.90 |
| Return on Invested Capital (ROIC) | 8.16 |
| Return on Capital Employed (ROCE) | 1.01 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.31 |
Taxes
Over the trailing twelve months, Dolby Laboratories, Inc. has paid 48.77M in income taxes, reflecting an effective tax rate of 17.62.
| Income Tax | 48.77M |
| Effective Tax Rate | 17.62 |
Stock Price Statistics
Dolby Laboratories, Inc.'s stock has declined approximately -14.31122% over the past 52 weeks. The 50-day moving average sits at 53.62, while the 200-day moving average is 60.61.
| Beta (5Y) | N/A |
| 52-Week Price Change | -14.31122% |
| 50-Day Moving Average | 53.62 |
| 200-Day Moving Average | 60.61 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Dolby Laboratories, Inc. generated 1.35B in revenue and converted that into 28.60M in net income, yielding earnings per share of 2.38. EBITDA reached 365.14M, while operating income came in at 261.83M.
| Revenue | 1.35B |
| Gross Profit | 1.19B |
| Operating Income | 261.83M |
| Pretax Income | 276.77M |
| Net Income | 28.60M |
| EBITDA | 365.14M |
| EBIT | 261.83M |
| Earnings Per Share (EPS) | 2.38 |
Balance Sheet
Dolby Laboratories, Inc. holds 670.05M in cash and equivalents against 47.45M in total debt, resulting in a net debt position of -669.39M. Total book value stands at 2.58B, with working capital of 909.71M providing operational flexibility.
| Cash & Cash Equivalents | 670.05M |
| Total Debt | 47.45M |
| Net Debt | -669.39M |
| Equity (Book Value) | 2.58B |
| Book Value Per Share | 27.59 |
| Working Capital | 909.71M |
Cash Flow
Dolby Laboratories, Inc. produced 437.60M in operating cash flow over the past twelve months. After subtracting -87.50M in capital expenditures, free cash flow totaled 350.10M - equivalent to 3.68 per share.
| Operating Cash Flow | 437.60M |
| Capital Expenditures | -87.50M |
| Free Cash Flow | 350.10M |
| FCF Per Share | 3.68 |
Margins
Dolby Laboratories, Inc. operates with a gross margin of 87.61, reflecting its pricing power and cost economics. The operating margin of 19.33 and net profit margin of 2.11 provide insight into operational efficiency.
| Gross Margin | 87.61 |
| Operating Margin | 19.33 |
| Pretax Margin | 20.44 |
| Profit Margin | 2.11 |
| EBITDA Margin | 26.96 |
Dividends & Yields
The company's payout ratio of 58.41 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 1.41 |
| Dividend Yield | N/A |
| Payout Ratio | 58.41 |
| Shareholder Yield | 7.65 |
| FCF Yield | 10.42 |
Scores
Dolby Laboratories, Inc. posts an Altman Z-Score of 8.33, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 8.33 |